Trial NCT00670748

View at ClinicalTrials.gov 
Org. Study IDs: 080121
Secondary IDs: 08-C-0121

Last trial update was posted on 2019-11-19

MeSH Interventions

Aldesleukin Cyclophosphamide Fludarabine Fludarabine phosphate

MeSH Conditions

Carcinoma, Renal Cell Melanoma Neoplasm Metastasis Neoplasms Neoplasms, Second Primary

Other Conditions

Metastatic Cancer Metastatic Melanoma Metastatic Renal Cell Cancer

Stopping Reasons

A more highly selected protocol with ESO TCR opened for pts with melanoma

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID